Hi Sharks, $10.8m Looks like revs $43-44m FY17 vs $37m FY16. 16% growth min. What I am liking most is the strong EBITDA trend. FY17 Q1. $2.2m Q2. $2.5m Q3. $3m
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025